Literature DB >> 28591322

Myocardial Viability on Cardiac Magnetic Resonance.

Ana Luiza Mansur Souto1, Rafael Mansur Souto2, Isabella Cristina Resende Teixeira3, Marcelo Souto Nacif1,2,3.   

Abstract

The study of myocardial viability is of great importance in the orientation and management of patients requiring myocardial revascularization or angioplasty. The technique of delayed enhancement (DE) is accurate and has transformed the study of viability into an easy test, not only for the detection of fibrosis but also as a binary test detecting what is viable or not. On DE, fibrosis equal to or greater than 50% of the segmental area is considered as non-viable, whereas that below 50% is considered viable. During the same evaluation, cardiac magnetic resonance (CMR) may also use other techniques for functional and perfusion studies to obtain a global evaluation of ischemic heart disease. This study aims to highlight the current concepts and broadly emphasize the use of CMR as a method that over the last 20 years has become a reference in the detection of infarction and assessment of myocardial viability. Resumo O estudo de viabilidade miocárdica é de grande importância para a orientação e manejo de pacientes que necessitam de cirurgia de revascularização miocárdica ou angioplastia. A técnica de realce tardio (RT) é precisa e transformou o estudo de viabilidade em um teste fácil, não só para a detecção de fibrose, mas também como um modelo binário para a detecção do que é ou não é viável. Uma fibrose identificada pelo RT é considerada como não viável quando igual ou maior do que 50% da área segmentar e como viável quando menor que 50%. A ressonância magnética cardíaca (RMC) também pode lançar mão de outras técnicas para estudo funcional e de perfusão para uma avaliação global da doença isquêmica do coração no mesmo exame. Este estudo tem como objetivo destacar os conceitos atuais e enfatizar amplamente o uso da RMC como um método que nos últimos 20 anos se tornou referência na detecção de infarto e avaliação de viabilidade miocárdica.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28591322      PMCID: PMC5444893          DOI: 10.5935/abc.20170056

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  71 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Waren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Int J Cardiovasc Imaging       Date:  2002-02       Impact factor: 2.357

2.  Measuring myocardial scar by CMR.

Authors:  Raymond Y Kwong; Afshin Farzaneh-Far
Journal:  JACC Cardiovasc Imaging       Date:  2011-02

Review 3.  Differentiation of myocardial scar from potential pitfalls and artefacts in delayed enhancement MRI.

Authors:  E B Turkbey; M S Nacif; R A Noureldin; C T Sibley; S Liu; J A C Lima; D A Bluemke
Journal:  Br J Radiol       Date:  2012-11       Impact factor: 3.039

4.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement.

Authors:  Anja Wagner; Heiko Mahrholdt; Louise Thomson; Stefan Hager; Gabriel Meinhardt; Wolfgang Rehwald; Michele Parker; Dipan Shah; Udo Sechtem; Raymond J Kim; Robert M Judd
Journal:  J Am Coll Cardiol       Date:  2006-04-27       Impact factor: 24.094

6.  Noninvasive identification of myocardium at risk in patients with acute myocardial infarction and nondiagnostic electrocardiograms with technetium-99m-Sestamibi.

Authors:  T F Christian; I P Clements; R J Gibbons
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

7.  Prevalence and Correlates of Myocardial Scar in a US Cohort.

Authors:  Evrim B Turkbey; Marcelo S Nacif; Mengye Guo; Robyn L McClelland; Patricia B R P Teixeira; Diane E Bild; R Graham Barr; Steven Shea; Wendy Post; Gregory Burke; Matthew J Budoff; Aaron R Folsom; Chia-Ying Liu; João A Lima; David A Bluemke
Journal:  JAMA       Date:  2015-11-10       Impact factor: 56.272

Review 8.  Assessment of myocardial ischemia and viability using cardiac magnetic resonance.

Authors:  Nuno Bettencourt; Amedeo Chiribiri; Andreas Schuster; Eike Nagel
Journal:  Curr Heart Fail Rep       Date:  2009-09

9.  Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study.

Authors:  Einar Heiberg; Martin Ugander; Henrik Engblom; Matthias Götberg; Göran K Olivecrona; David Erlinge; Håkan Arheden
Journal:  Radiology       Date:  2007-11-30       Impact factor: 11.105

10.  Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance.

Authors:  Sujethra Vasu; W Patricia Bandettini; Li-Yueh Hsu; Peter Kellman; Steve Leung; Christine Mancini; Sujata M Shanbhag; Joel Wilson; Oscar Julian Booker; Andrew E Arai
Journal:  J Cardiovasc Magn Reson       Date:  2013-09-24       Impact factor: 5.364

View more
  5 in total

Review 1.  Advances in MRI Applications to Diagnose and Manage Cardiomyopathies.

Authors:  Ramya Vajapey; Brendan Eck; Wilson Tang; Deborah H Kwon
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-27

Review 2.  Assessment of myocardial viability by cardiac MRI.

Authors:  Basil Al-Sabeq; Faisal Nabi; Dipan J Shah
Journal:  Curr Opin Cardiol       Date:  2019-09       Impact factor: 2.161

3.  Validity of resting strain/strain rate in prediction of myocardial viability.

Authors:  Amr Hanafy; Soliman Ghareb Ibrahim; Hossam-Eldein Mohamed Mohamed Mansour; Aml Mohamed Soliman; Mohamed Kamal Salama
Journal:  Int J Cardiovasc Imaging       Date:  2021-09-18       Impact factor: 2.357

Review 4.  Early Detection and Monitoring of Cancer Chemotherapy-Related Left Ventricular Dysfunction by Imaging Methods.

Authors:  Mario Luiz Ribeiro; Antonio José Lagoeiro Jorge; Marcelo Souto Nacif; Wolney de Andrade Martins
Journal:  Arq Bras Cardiol       Date:  2019-02-21       Impact factor: 2.000

5.  Microencapsulated Insulin-Like Growth Factor-1 therapy improves cardiac function and reduces fibrosis in a porcine acute myocardial infarction model.

Authors:  Claudia Báez-Díaz; Virginia Blanco-Blázquez; Francisco-Miguel Sánchez-Margallo; Antoni Bayes-Genis; Irene González; Ana Abad; Rob Steendam; Okke Franssen; Itziar Palacios; Belén Sánchez; Carolina Gálvez-Montón; Verónica Crisóstomo
Journal:  Sci Rep       Date:  2020-04-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.